Winter Street Ventures

Winter Street Ventures

Winter Street Ventures was formed in Boston as the venture investment arm of Commonwealth Care Alliance (CCA), a Massachusetts-based managed-care plan serving individuals dually eligible for Medicare and Medicaid. Founder Chris Palmieri, who served as CCA's CEO, established the firm to invest in early-stage companies that address the clinical and operational complexities of caring for high-need populations. The firm became an independent entity in 2025 when CareSource acquired CCA, giving Palmieri full control of the venture portfolio and strategy. Its headquarters remain on Beacon Hill, embedded in the healthcare policy ecosystem of Boston. The firm makes direct seed and early-stage venture investments across digital health, healthcare services, and enterprise software for payers and providers. Its mandate covers companies building tools for care management, behavioral health integration, and administrative simplification — areas Palmieri navigated firsthand while running a plan with complex risk pools and thin margins. Confirmed portfolio exposure is limited, but the firm's structure as a spinout from an operating care-delivery organization mirrors other operator-founded venture platforms such as Ascension Ventures or Providence Ventures. Geographic focus is primarily US-based, with a likely emphasis on the Northeast corridor where CCA operated and where Palmieri maintains his deepest relationships with state Medicaid agencies and provider networks. The firm operates from a single Boston office and invests through Winter Street Ventures Fund I LP. Team size and total deployment are not publicly disclosed. Palmieri brings governance depth beyond his operating background: he served as Chair of the Board for the Association of Community Affiliated Plans (ACAP) and sits on the Board of Trustees at Ithaca College. The firm's mentors participate in VentureOut's Healthtech programs, signaling a willingness to engage the broader startup ecosystem beyond just capital deployment. In 2025, Winter Street Ventures achieved independence from CCA following that entity's acquisition by CareSource. Winter Street Ventures' structural differentiator is its founder's operating DNA. Palmieri did not come from a traditional venture background — he ran a complex, highly regulated health plan serving some of the sickest and most expensive patients in the US system. That gives the firm an unusual ability to diligence startups on their clinical validity and reimbursement feasibility, not just their market size and team. For an allocator evaluating early-stage healthtech managers, this operator-to-investor transition is the defining feature: a generalist venture label applied to a healthcare strategy built by someone who spent his career managing downside risk in value-based care contracts.